section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: bradycardia, hypertension, palpitations, tachycardia

GI: nausea, vomiting

Neuro: dizziness, restlessness

Misc: tolerance

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

US Brand Names

Akovaz, Corphedra, Emerphed, Rezipres

Action

  • Acts as an agonist at both alpha- and beta-receptors; also indirectly stimulates release of norepinephrine, which results in vasoconstriction and increased cardiac output.
Therapeutic effects:
  • Increased BP.

Classifications

Therapeutic Classification: vasopressors

Pharmacologic Classification: adrenergics

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Metabolized into norephedrine. Primarily excreted as unchanged drug and metabolite in urine.

Half-Life: 6 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
IVunknownunknownunknown



Patient/Family Teaching

Pronunciation

e-FED-rin